Korean J healthc assoc Infect Control Prev.  2023 Dec;28(2):243-244. 10.14192/kjicp.2023.28.2.243.

Changing Epidemiology of Multidrug-resistant Pathogens: A New Battle against Carbapenem-resistant Enterobacterales

• Chong YP

• KMID: 2549953
• DOI: http://doi.org/10.14192/kjicp.2023.28.2.243

Figure

• 

  Fig. 1 Trends of intensive care unit-acquired Staphylococcus aureus bacteremia in Asan Medical Center.

• 

  Fig. 2 Trends of Klebsiella pneumoniae bacteremia in Asan Medical Center.

Reference

1. Kim H, Kim ES, Lee SC, Yang E, Kim HS, Sung H, et al. 2020; Decreased incidence of methicillin-resistant Staphylococcus aureus bacteremia in intensive care units: a 10-year clinical, microbiological, and genotypic analysis in a tertiary hospital. Antimicrob Agents Chemother. 64:e01082–20. DOI: 10.1128/AAC.01082-20. PMID: 32747360. PMCID: PMC7508613.

2. Choi SH, Lee J, Jung J, Kim ES, Kim MJ, Chong YP, et al. 2021; A longitudinal study of adult patients with Staphylococcus aureus bacteremia over 11 years in Korea. J Korean Med Sci. 36:e104. DOI: 10.3346/jkms.2021.36.e104. PMID: 33904260. PMCID: PMC8076844.

3. Seo H, Kim H, Park S, Chung H, Bae S, Sung H, et al. 2023; Trend of beta-lactam resistance in Escherichia coli and Klebsiella pneumoniae bacteremia and clinical characteristics of cefotaxime-susceptible extended-spectrum beta-lactamase-producing isolates. Korean J healthc assoc Infect Control Prev. 28:126–34. DOI: 10.14192/kjicp.2023.28.1.126.

4. Kang SW, Park S, Kim AR, Han J, Lee J, Seo H, et al. 2023; Clinical characteristics of and risk factors for subsequent carbapenemase-producing Enterobacterales (CPE) bacteraemia in rectal CPE carriers. Int J Antimicrob Agents. 62:106959. DOI: 10.1016/j.ijantimicag.2023.106959. PMID: 37633425.

5. Seo H, Kim HJ, Kim MJ, Chong YP, Kim SH, Lee SO, et al. 2021; Comparison of clinical outcomes of patients infected with KPC- and NDM-producing Enterobacterales: a retrospective cohort study. Clin Microbiol Infect. 27:1167.e1–8. DOI: 10.1016/j.cmi.2020.09.043. PMID: 33010443.

6. Seo H, Lee SC, Chung H, Ra SH, Sung H, Kim MN, et al. 2020; Clinical and microbiological analysis of risk factors for mortality in patients with carbapenem-resistant Enterobacteriaceae bacteremia. Int J Antimicrob Agents. 56:106126. DOI: 10.1016/j.ijantimicag.2020.106126. PMID: 32755654.